| Disease Info Index | ||||||||||||||||||||||||||
|
|

Dengue / Dengue Hemorrhagic Fever | |
Glossary |
|
Text
|
Purpura - A condition characterized by hemorrhages in the skin and mucous membranes that result in the appearance of purplish spots or patches Epistaxis - Nosebleed Hematemesis - Blood vomit Thrombocytopenia - An abnormal decrease in the number of platelets in circulatory blood Immunohistochemistry - Microscopic localization of specific antigens in tissues by staining with antibodies labeled with fluorescent or pigmented material. Immunofluorescence - labeling of antibodies or antigens with fluorescent dyes especially for the purpose of demonstrating the presence of a particular antigen or antibody in a tissue preparation or smear Polymerase Chain Reaction - in vitro technique for rapidly synthesizing large quantities of a given DNA segment that involves separating the DNA into its two complementary strands, binding a primer to each single strand at the end of the given DNA segment where synthesis will start, using DNA polymerase to synthesize two-stranded DNA from each single strand, and repeating the process Enzyme Immuno Assay - An assay that uses an enzyme-bound antibody to detect antigen Analgesics - Drugs that reduce pain. |
| Share it! |
|
|
|
|




|
|
|
Posted by:
Tewari55
Posted on: 07/23/2010 The platelet count is not the only important determinant of bleeding. Indications for blood/platelet transfusion as recommended in clinical practice guidelines are: In cases with significant clinical bleeding, which require blood transfusion. Usually bleeding is > 10% of total blood volume (> 6-8 ml/kg of ideal body weight) In adults with underlying hypertension or coronary heart diseases and platelet 1.3-1.5, which is the result of liver failure: Major contributing factor for massive bleeding. There is no evidence to support the use of blood components such as platelet concentrates, fresh frozen plasma or cryoprecipitate. Its use could contribute to fluid overload. Important instructions for treatment of DHF as per WHO/SEARO guidelines: If the patient’s condition becomes worse despite giving 20ml/kg/hr crystalloid solution for one hour, replace crystalloid solution with colloid solution such as Dextran or Plasma. As soon as improvement occurs, replace with crystalloid. In case of severe bleeding; give blood transfusion @ 20ml/kg for two hours. Then give crystalloid IV fluids @ 10 ml/kg/hr for a short time (30 - 60 minutes) and later reduce the speed. If hematocrit falls, give blood transfusion 10 ml/kg and then give crystalloid IV fluids at the rate of 10 ml/kg/hr. The volume of blood administered should be just enough to raise the red blood cell concentration to normal. |
| Citing this Health Article | ||||||
|
||||||
| News on Dengue / Dengue Hemorrhagic Fever |
| * New Portable Tool To Detect Dengue Mosquitoes Developed |
| * Dengue Fever: A Major Cost Burden |
| * Britain At Risk of Dengue Spread Due to Climate Change |
| * Dengue Epidemic in Rio |
| * Achilles Heel of Dengue Virus Identified |
| Total News Item 237 |
As my Mother in ICU>Please Reply